Group 2:IMRT

2 trials

Sponsors

Zhongshan Hospital, Fudan University, Eye, Ear, Nose, and Throat Hospital, Fudan University

Conditions

III non-small cell lung cancerrecurrent nasopharyngeal carcinoma

Phase 3

Comparison of hypofractionated helical tomotherapy (TOMO) concurrent chemoradiation therapy versus conventional intensity-modulated radiation therapy concurrent chemoradiation therapy for the inoperable stage III non-small cell lung cancer: a prospective, randomized, multicenter controlled trial

RecruitingChiCTR1800017367

Zhongshan Hospital, Fudan UniversityIII non-small cell lung cancer

Start: 2018-07-19Updated: 2018-07-31

Unknown Phase

A Multicenter Randomized Controlled Trial for Comparing Endonasal Surgery and Radiation Therapy (IMRT) for T1-T2 Recurrent Nasopharyngeal Carcinoma

RecruitingChiCTR1900026727

Eye, Ear, Nose, and Throat Hospital, Fudan Universityrecurrent nasopharyngeal carcinoma

Start: 2021-03-01Updated: 2021-03-01